SMS Lifesciences India's Stock Hits 52-Week High, Outperforms Sector and Benchmark Index

May 28 2024 09:36 AM IST
share
Share Via
SMS Lifesciences India . has been making headlines in the stock market as its share price reached a 52-week high of Rs.821.15 on May 28, 2024. The stock has outperformed the sector by 19.66% and gained 24.79% in the last two days. With a 'Hold' recommendation from MarketsMojo, the stock is currently trading higher than its moving averages and has shown a 1-year performance of 46.63%, surpassing the Sensex's 20.71%.

SMS Lifesciences India ., a microcap pharmaceutical company, has been making waves in the stock market as its share price hit a 52-week high of Rs.821.15 on May 28, 2024. The stock has been performing well, outperforming the sector by 19.66% and gaining 24.79% in the last two days alone.

Investors may be wondering what is driving this surge in SMS Lifesciences' stock price. According to MarketsMOJO, a leading stock analysis and recommendation platform, the current call for the stock is 'Hold'. This means that while the stock is performing well, it may not be the best time to buy or sell.

The stock opened today with a gain of 6.33% and reached an intraday high of Rs.821.15, which is a 20% increase from its previous closing price. The stock has also been highly volatile today, with an intraday volatility of 8.75%. This can be attributed to the stock's strong performance and investor interest.

SMS Lifesciences is also trading higher than its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a positive trend in its stock price. In comparison to the Sensex, a benchmark index for the Indian stock market, SMS Lifesciences has outperformed with a 1-year performance of 46.63% versus Sensex's 20.71%.

Overall, SMS Lifesciences India . is showing strong performance in the stock market, with its share price reaching a new high and outperforming the sector and benchmark index. Investors may want to keep an eye on this microcap company as it continues to make strides in the pharmaceutical industry.
{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News